ValuentumAd

Official PayPal Seal













Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Jul 24, 2018
FERC Clarifies MLP Tax Changes
Image shown: The prices of MLPs have collapsed since mid-June 2015 as the stock market has surged. The status quo for many MLPs looks to be restored, though that doesn’t mean MLPs are out of the woods. We continue to expect many to transition to corporates in coming years, and the idea of consolidation/buyouts may bring new investor capital to the space.
Jul 23, 2018
Hasbro Shares Jump Despite Transient Challenges
Image Source: William Warby. Simulated Dividend Growth Newsletter idea Hasbro turned in another lackluster quarterly report, but its second-quarter results were better than expected as the company continues to work through a variety of what it believes are transient issues.
Jul 22, 2018
Strong Finish to Fiscal 2018 for Cash-Rich Microsoft
Simulated Dividend Growth Newsletter portfolio idea Microsoft turned in a solid fiscal 2018 fourth quarter report. The company continues to throw off tremendous amounts of cash even as it continues to invest materially in future growth opportunities.
Jul 20, 2018
Dividend Increases/Decreases for the Week Ending July 20
We provide a list of firms that raised/lowered their dividends during the week ending July 20. The dividend reports of covered firms on this list will be updated shortly with the new information. To access our dividend reports use the ‘Symbol’ search box in our website header.
Jul 19, 2018
Johnson & Johnson Powers Ahead, Litigation Overhang Remains
Image Source: J&J quarterly presentation. Amid headline pressure from consumer lawsuits, Johnson & Johnson continues to execute well, as evidenced by its solid second quarter report.
Jul 13, 2018
What Are the Downside Risks of Gilead Sciences?
We think the risk-reward at Gilead remains positively skewed in investors’ favor, but let’s examine the downside case for Gilead Sciences so there are no surprises. It’s always a good approach to evaluate where an investor may go wrong with an investment idea, and assessing upside and downside cases, as in a fair value range, remains par for the course.
Jul 13, 2018
Dividend Increases/Decreases for the Week Ending July 13
Let's take a look at companies that raised/lowered their dividend this week.
Jul 11, 2018
In the News: More Tariff Talk Keeps Markets Volatile
Many market observers were caught by surprise after President Trump continued down a path of escalating trade tensions late July 10.
Jul 11, 2018
What Are the Qualities of Highly-Rated Stocks on the Valuentum Buying Index?
Let’s walk through the seven most important considerations CEOs should focus on to score a high rating on the Valuentum Buying Index.
Jul 10, 2018
Biogen Hits a Potential Home Run
We closely follow the progress of the clinical pipeline of companies in the pharma/biotech sector. Unlike other less product-driven industries, the pharma/biotech sector can experience wide swings in operating performance as a result of the lapsing of patent protection on key drugs, underscoring the importance of innovation to replace aging products. Biogen may have hit a home run in the critical field of Alzheimer's, an area of tremendous untapped need.


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.